200 related articles for article (PubMed ID: 22069042)
1. Malignant pheochromocytoma: new malignancy criteria.
de Wailly P; Oragano L; Radé F; Beaulieu A; Arnault V; Levillain P; Kraimps JL
Langenbecks Arch Surg; 2012 Feb; 397(2):239-46. PubMed ID: 22069042
[TBL] [Abstract][Full Text] [Related]
2. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis.
Strong VE; Kennedy T; Al-Ahmadie H; Tang L; Coleman J; Fong Y; Brennan M; Ghossein RA
Surgery; 2008 Jun; 143(6):759-68. PubMed ID: 18549892
[TBL] [Abstract][Full Text] [Related]
3. COPPS, a composite score integrating pathological features, PS100 and SDHB losses, predicts the risk of metastasis and progression-free survival in pheochromocytomas/paragangliomas.
Pierre C; Agopiantz M; Brunaud L; Battaglia-Hsu SF; Max A; Pouget C; Nomine C; Lomazzi S; Vignaud JM; Weryha G; Oussalah A; Gauchotte G; Busby-Venner H
Virchows Arch; 2019 Jun; 474(6):721-734. PubMed ID: 30868297
[TBL] [Abstract][Full Text] [Related]
4. Size of the tumor and pheochromocytoma of the adrenal gland scaled score (PASS): can they predict malignancy?
Agarwal A; Mehrotra PK; Jain M; Gupta SK; Mishra A; Chand G; Agarwal G; Verma AK; Mishra SK; Singh U
World J Surg; 2010 Dec; 34(12):3022-8. PubMed ID: 20703467
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of morphology of adrenal pheochromocytoma as regards their potential malignancy].
Kajor M; Ziaja J; Lange D; Król R; Ciupińska-Kajor M; Turska-d'Amico M; Maka B; Cierpka L
Endokrynol Pol; 2005; 56(6):911-6. PubMed ID: 16821210
[TBL] [Abstract][Full Text] [Related]
6. Paraganglioma: not just an extra-adrenal pheochromocytoma.
Laird AM; Gauger PG; Doherty GM; Miller BS
Langenbecks Arch Surg; 2012 Feb; 397(2):247-53. PubMed ID: 22086065
[TBL] [Abstract][Full Text] [Related]
7. Predicting Metastatic Potential in Pheochromocytoma and Paraganglioma: A Comparison of PASS and GAPP Scoring Systems.
Wachtel H; Hutchens T; Baraban E; Schwartz LE; Montone K; Baloch Z; LiVolsi V; Krumeich L; Fraker DL; Nathanson KL; Cohen DL; Fishbein L
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4661-70. PubMed ID: 32877928
[TBL] [Abstract][Full Text] [Related]
8. Should pheochromocytoma size influence surgical approach? A comparison of 90 malignant and 60 benign pheochromocytomas.
Shen WT; Sturgeon C; Clark OH; Duh QY; Kebebew E
Surgery; 2004 Dec; 136(6):1129-37. PubMed ID: 15657566
[TBL] [Abstract][Full Text] [Related]
9. Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases.
Thompson LD
Am J Surg Pathol; 2002 May; 26(5):551-66. PubMed ID: 11979086
[TBL] [Abstract][Full Text] [Related]
10. Observer variation in the application of the Pheochromocytoma of the Adrenal Gland Scaled Score.
Wu D; Tischler AS; Lloyd RV; DeLellis RA; de Krijger R; van Nederveen F; Nosé V
Am J Surg Pathol; 2009 Apr; 33(4):599-608. PubMed ID: 19145205
[TBL] [Abstract][Full Text] [Related]
11. Retrospective application of the pathologic tumor-node-metastasis classification system for pheochromocytoma and abdominal paraganglioma in a well characterized cohort with long-term follow-up.
Stenman A; Zedenius J; Juhlin CC
Surgery; 2019 Nov; 166(5):901-906. PubMed ID: 31239074
[TBL] [Abstract][Full Text] [Related]
12. Lack of correlations among histopathological parameters, Ki-67 proliferation index and prognosis in pheochromocytoma patients.
Ocal I; Avci A; Cakalagaoglu F; Can H
Asian Pac J Cancer Prev; 2014; 15(4):1751-5. PubMed ID: 24641403
[TBL] [Abstract][Full Text] [Related]
13. SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma.
Assadipour Y; Sadowski SM; Alimchandani M; Quezado M; Steinberg SM; Nilubol N; Patel D; Prodanov T; Pacak K; Kebebew E
Surgery; 2017 Jan; 161(1):230-239. PubMed ID: 27839933
[TBL] [Abstract][Full Text] [Related]
14. [Pheochromocytoma: role of preoperative diagnosis in the assessment of malignancy risk and in the choice of surgical approach].
Lombardi CP; Raffaelli M; De Crea C; Traini E; D'Amore AM; Bellantone R
Suppl Tumori; 2005; 4(3):S211. PubMed ID: 16437995
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopic treatment of pheochromocytomas smaller or larger than 6 cm. A clinical retrospective study on 44 patients. Laparoscopic adrenalectomy for pheochromocytoma.
Conzo G; Musella M; Corcione F; De Palma M; Avenia N; Milone M; Della Pietra C; Palazzo A; Parmeggiani D; Pasquali D; Sinisi AA; Santini L
Ann Ital Chir; 2013; 84(4):417-22. PubMed ID: 23093462
[TBL] [Abstract][Full Text] [Related]
16. Pheochromocytoma in Dogs Undergoing Adrenalectomy.
Zini E; Nolli S; Ferri F; Massari F; Gerardi G; Nicoli S; Romanelli G; Montinaro V; Trez D; Cavicchioli L; Ferro S
Vet Pathol; 2019 May; 56(3):358-368. PubMed ID: 30595108
[TBL] [Abstract][Full Text] [Related]
17. Pheochromocytoma in children and adolescents: a clinical spectrum.
Bissada NK; Safwat AS; Seyam RM; Al Sobhi S; Hanash KA; Jackson RJ; Sakati N; Bissada MA
J Pediatr Surg; 2008 Mar; 43(3):540-3. PubMed ID: 18358297
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic adrenalectomy in large adrenal tumors.
Asari R; Koperek O; Niederle B
Surgery; 2012 Jul; 152(1):41-9. PubMed ID: 22483579
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine markers and sustentacular cell count in benign and malignant pheochromocytomas - a comparative study.
Białas M; Okoń K; Dyduch G; Ciesielska-Milian K; Buziak M; Hubalewska-Dydejczyk A; Sobrinho-Simoes M
Pol J Pathol; 2013 Jun; 64(2):129-35. PubMed ID: 23900871
[TBL] [Abstract][Full Text] [Related]
20. Clinical course and prognostic factors in patients with malignant pheochromocytoma and paraganglioma: A single institution experience.
Choi YM; Sung TY; Kim WG; Lee JJ; Ryu JS; Kim TY; Kim WB; Hong SJ; Song DE; Shong YK
J Surg Oncol; 2015 Dec; 112(8):815-21. PubMed ID: 26464058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
